Yahoo Finance Live looks at several notable gains and losses from today's trending tickers. Read More...
Reuters
Germans pin hopes on Novavax moving the needle among anti-vaxxers
Benedikt Richter, a 40-year-old teacher in the southwest German city of Kaiserslautern, long held out against getting vaccinated against COVID-19. It did not help that his sister-in-law was hospitalised with heart muscle inflammation a day after receiving her second shot, which doctors officially linked to her vaccine, Richter said. But when the European Union in December approved the use of the Novavax vaccine Nuxavoxid, which deploys a long-established protein-based technology, he became interested.
Add Comment